TiumBio Co., Ltd. (KOSDAQ:321550)

TiumBio Statistics

Total Valuation

TiumBio has a market cap or net worth of KRW 178.83 billion. The enterprise value is 181.82 billion.

Market Cap	178.83B
Enterprise Value	181.82B

Important Dates

The next estimated earnings date is Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

TiumBio has 29.08 million shares outstanding. The number of shares has increased by 4.33% in one year.

Current Share Class	29.08M
Shares Outstanding	29.08M
Shares Change (YoY)	+4.33%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	33.70%
Owned by Institutions (%)	0.04%
Float	19.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.18
PB Ratio	3.68
P/TBV Ratio	5.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-15.50
EV / Sales	19.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.79

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.76.

Current Ratio	1.95
Quick Ratio	1.64
Debt / Equity	0.76
Debt / EBITDA	n/a
Debt / FCF	-2.60
Interest Coverage	-3.75

Financial Efficiency

Return on equity (ROE) is -25.94% and return on invested capital (ROIC) is -13.80%.

Return on Equity (ROE)	-25.94%
Return on Assets (ROA)	-11.74%
Return on Invested Capital (ROIC)	-13.80%
Return on Capital Employed (ROCE)	-24.83%
Weighted Average Cost of Capital (WACC)	7.36%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +67.78% in the last 52 weeks. The beta is 0.45, so TiumBio's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+67.78%
50-Day Moving Average	5,997.40
200-Day Moving Average	5,803.45
Relative Strength Index (RSI)	56.37
Average Volume (20 Days)	197,954

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TiumBio had revenue of KRW 9.32 billion and -11.73 billion in losses. Loss per share was -441.55.

Revenue	9.32B
Gross Profit	7.91B
Operating Income	-18.57B
Pretax Income	-13.53B
Net Income	-11.73B
EBITDA	-14.91B
EBIT	-18.57B
Loss Per Share	-441.55

Balance Sheet

The company has 45.27 billion in cash and 36.95 billion in debt, with a net cash position of 8.32 billion or 285.96 per share.

Cash & Cash Equivalents	45.27B
Total Debt	36.95B
Net Cash	8.32B
Net Cash Per Share	285.96
Equity (Book Value)	48.57B
Book Value Per Share	1,372.58
Working Capital	27.14B

Cash Flow

In the last 12 months, operating cash flow was -14.10 billion and capital expenditures -115.68 million, giving a free cash flow of -14.22 billion.

Operating Cash Flow	-14.10B
Capital Expenditures	-115.68M
Free Cash Flow	-14.22B
FCF Per Share	-489.01

Margins

Gross margin is 84.80%, with operating and profit margins of -199.18% and -125.81%.

Gross Margin	84.80%
Operating Margin	-199.18%
Pretax Margin	-145.13%
Profit Margin	-125.81%
EBITDA Margin	-159.90%
EBIT Margin	-199.18%
FCF Margin	n/a

Dividends & Yields

TiumBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.33%
Shareholder Yield	-4.33%
Earnings Yield	-6.56%
FCF Yield	-7.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TiumBio has an Altman Z-Score of 0.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.76
Piotroski F-Score	3